New Biocalysis Technology

BiotechnologySeries CWuhan, Chinahzymes.com

Latest round

Series C

Last raised

Nov 2021

Total raised

$125M

Investors

8

About New Biocalysis Technology

Established in 2015 and based in Wuhan, China, New Biocalysis Technology is a company focusing on the research and development, production, and technology of raw materials for bio-pharmaceutical and IVD industry. The company has developed more than 100 raw materials of IVD reagents, its IVD products are used in bio-pharmaceutical, vaccine production, molecular diagnosis, and bio-sensing etc. The company is in partnership with over 100 IVD reagent manufacturers, and selling the products to 25 countries.

Who invested in New Biocalysis Technology

8 investors across 1 round

See all investors in New Biocalysis Technology

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Nov 5, 2021

    Amount

    $125M

    Investors

    Locked

Questions about New Biocalysis Technology

Who invested in New Biocalysis Technology?

New Biocalysis Technology has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has New Biocalysis Technology raised?

New Biocalysis Technology has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did New Biocalysis Technology last raise money?

New Biocalysis Technology's most recent round on record is a Series C, in Nov 2021.

What does New Biocalysis Technology do?

Established in 2015 and based in Wuhan, China, New Biocalysis Technology is a company focusing on the research and development, production, and technology of raw materials for bio-pharmaceutical and IVD industry.

Where is New Biocalysis Technology headquartered?

New Biocalysis Technology is headquartered in Wuhan, China.

Which VCs invest in companies like New Biocalysis Technology?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at New Biocalysis Technology's stage. Their profiles are linked below.

Raising like New Biocalysis Technology? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.